Roberta Soscia

Pubblicazioni

Titolo Pubblicato in Anno
Sialylation regulates migration in chronic lymphocytic leukemia HAEMATOLOGICA 2023
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet {PCR} improve measurable residual disease monitoring in chronic lymphoid malignancies? FRONTIERS IN ONCOLOGY 2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia CANCERS 2023
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia CANCERS 2023
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia HAEMATOLOGICA 2022
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia THE JOURNAL OF MOLECULAR DIAGNOSTICS 2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases HEMATOLOGICAL ONCOLOGY 2022
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia HEMASPHERE 2021
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma HEMATOLOGICAL ONCOLOGY 2020
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia LEUKEMIA & LYMPHOMA 2019
Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances FRONTIERS IN ONCOLOGY 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma